Genome wide assessment of young onset Parkinson's disease from Finland

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Hernandez, Dena G ^a   Nalls, Michael A ^a   Ylikotila, Pauli ^b   Keller, Margaux ^a   Hardy, John A ^c   Majamaa, Kari ^d   Singleton, Andrew B ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLELE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FINLAND; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HOMOZYGOSITY; HUMAN; HUMAN GENOME; MAJOR CLINICAL STUDY; ONSET AGE; PARKINSON DISEASE; PENETRANCE; POPULATION BASED CASE CONTROL STUDY; POPULATION GENETICS; POPULATION RESEARCH; RISK ASSESSMENT;

AGE OF ONSET; AGED; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FINLAND; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MIDDLE AGED; PARKINSON DISEASE; RISK FACTORS;

EID: 84864200185     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041859     Document Type: Article

References (20)

1. Hardy J, Singleton A, (2009) Genomewide Association Studies and Human Disease. New England Journal of Medicine 360: 1759-1768 doi:10.1056/NEJMra0808700.
2. Pankratz N, Wilk JB, Latourelle JC, DeStefano AL, Halter C, et al. (2009) Genomewide association study for susceptibility genes contributing to familial Parkinson disease. Hum Genet 124: 593-605 doi:10.1007/s00439-008-0582-9.
3. Satake W, Nakabayashi Y, Mizuta I, Hirota Y, Ito C, et al. (2009) Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet 41: 1303-1307 doi:ng.485 [pii] 10.1038/ng.485.
4. Simon-Sanchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, et al. (2009) Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet 41: 1308-1312 doi:ng.487 [pii] 10.1038/ng.487.
5. Do CB, Tung JY, Dorfman E, Kiefer AK, Drabant EM, et al. (2011) Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease. PLoS Genet 7: e1002141 doi:10.1371/journal.pgen.1002141 PGENETICS-D-11-00444 [pii].
6. International Parkinson Disease Genomics Consortium, Nalls MA, Plagnol V, Hernandez DG, Sharma M, et al. (2011) Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet 377: 641-649 doi:S0140-6736(10)62345-8 [pii] 10.1016/S0140-6736(10)62345-8.
7. International Parkinson's Disease Genomics Consortium, Wellcome Trust Case Control Consortium, (2011) A two-stage meta-analysis identifies several new loci for Parkinson's disease. PLoS Genet 7: e1002142 doi:10.1371/journal.pgen.1002142 PGENETICS-D-11-00446 [pii].
8. Saad M, Lesage S, Saint-Pierre A, Corvol JC, Zelenika D, et al. (2011) Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population. Hum Mol Genet 20: 615-627 doi:ddq497 [pii] 10.1093/hmg/ddq497.
9. Singleton A, Hardy J, (2011) A generalizable hypothesis for the genetic architecture of disease: pleomorphic risk loci. Human Molecular Genetics 20: R158-R162 doi:10.1093/hmg/ddr358.
10. Laaksovirta H, Peuralinna T, Schymick JC, Scholz SW, Lai S-L, et al. (2010) Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study. Lancet Neurol 9: 978-985 doi:10.1016/S1474-4422(10)70184-8.
11. Gibbs JR, Singleton A, (2006) Application of genome-wide single nucleotide polymorphism typing: simple association and beyond. PLoS Genet 2: e150 doi:10.1371/journal.pgen.0020150.
12. Renton AE, Majounie E, Waite A, Simón-Sánchez J, Rollinson S, et al. (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72: 257-268 doi:10.1016/j.neuron.2011.09.010.
13. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, et al. (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72: 245-256 doi:S0896-6273(11)00828-2 [pii] 10.1016/j.neuron.2011.09.011.
14. Autere JM, Moilanen JS, Myllyla VV, Majamaa K, (2000) Familial aggregation of Parkinson's disease in a Finnish population. J Neurol Neurosurg Psychiatry 69: 107-109.
15. Moilanen JS, Autere JM, Myllyla VV, Majamaa K, (2001) Complex segregation analysis of Parkinson's disease in the Finnish population. Hum Genet 108: 184-189.
16. Payami H, Zareparsi S, James D, Nutt J, (2002) Familial aggregation of Parkinson disease: a comparative study of early-onset and late-onset disease. Arch Neurol 59: 848-850 doi:noc10257 [pii].
17. Skol AD, Scott LJ, Abecasis GR, Boehnke M, (2006) Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 38: 209-213 doi:10.1038/ng1706.
18. Nalls MA, Simon-Sanchez J, Gibbs JR, Paisan-Ruiz C, Bras JT, et al. (2009) Measures of autozygosity in decline: globalization, urbanization, and its implications for medical genetics. PLoS Genet 5: e1000415 doi:10.1371/journal.pgen.1000415.
19. Li Y, Willer C, Sanna S, Abecasis G, (2009) Genotype Imputation. Annu Rev Genomics Hum Genet 10: 387-406 doi:10.1146/annurev.genom.9.081307.164242.
20. Ripatti S, Tikkanen E, Orho-Melander M, Havulinna AS, Silander K, et al. (2010) A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses. Lancet 376: 1393-1400 doi:10.1016/S0140-6736(10)61267-6.